Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Srichai, Manakan B ^a,b   Colleta, Heloisa ^b   Gewin, Leslie ^b   Matrisian, Linsey ^b   Abel, Ty W ^b   Koshikawa, Naohiko ^d   Seiki, Motoharu ^d   Pozzi, Ambra ^a,b,c   Harris, Raymond C ^a,b   Zent, Roy ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE 17; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEEDING DISORDER; FLUID INTAKE; HOMEOSTASIS; HYPODIPSIA; HYPOTHALAMUS; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; KIDNEY DEVELOPMENT; KIDNEY TUBULE DISORDER; MOUSE; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; THIRST; URINE OSMOLALITY; URINE VOLUME; WILD TYPE; ANIMAL; ANTERIOR HYPOTHALAMUS; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; KIDNEY MEDULLA; METABOLISM; OSMOLARITY; PHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HYPOTHALAMUS, ANTERIOR; KIDNEY MEDULLA; MATRIX METALLOPROTEINASE 17; MICE; OSMOLAR CONCENTRATION; WATER;

EID: 79951826134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017099     Document Type: Article

References (26)

1. Itoh Y, Seiki M, (2006) MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206: 1-8.
2. Seiki M, (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194: 3.
3. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C, (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944-949.
4. Pei D, (1999) Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 274: 8925-8932.
5. English WR, Puente XS, Freije JM, Knauper V, Amour A, et al. (2000) Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 275: 14046-14055.
6. Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brule F, et al. (2006) Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res 66: 5165-5172.
7. Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, et al. (2003) Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 1: 333-345.
8. Rikimaru A, Komori K, Sakamoto T, Ichise H, Yoshida N, et al. (2007) Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using beta-galactosidase. Genes Cells 12: 1091-1100.
9. Riggins KS, Mernaugh G, Su Y, Quaranta V, Koshikawa N, et al. (2010) MT1-MMP-mediated basement membrane remodeling modulates renal development. Exp Cell Res 316: 2993-3005.
10. Catania JM, Chen G, Parrish AR, (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: F905-911.
11. Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, et al. (2006) Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 3: e100.
12. Wang X, Zhou Y, Tan R, Xiong M, He W, et al. (2010) Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 299: F973-982.
13. Ermolli M, Schumacher M, Lods N, Hammoud M, Marti HP, (2003) Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection. Transpl Immunol 11: 137-145.
14. Husted RF, Hayashi M, Stokes JB, (1988) Characteristics of papillary collecting duct cells in primary culture. Am J Physiol 255: F1160-1169.
15. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J, et al. (1996) Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10: 836-850.
16. Boyle S, Shioda T, Perantoni AO, de Caestecker M, (2007) Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev Dyn 236: 2321-2330.
17. Ge Y, Ahn D, Stricklett PK, Hughes AK, Yanagisawa M, et al. (2005) Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am J Physiol Renal Physiol 288: F912-920.
18. Srichai MB, Hao C, Davis L, Golovin A, Zhao M, et al. (2008) Apoptosis of the thick ascending limb results in acute kidney injury. J Am Soc Nephrol 19: 1538-1546.
19. Lelongt B, Ronco P, (2002) Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. Nephrol Dial Transplant 17 (Suppl 9): 28-31.
20. Lelongt B, Trugnan G, Murphy G, Ronco PM, (1997) Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136: 1363-1373.
21. Ronco P, Lelongt B, Piedagnel R, Chatziantoniou C, (2007) Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin. Semin Nephrol 27: 352-362.
22. Haas CS, Gleason B, Lin S, Tramonti G, Kanwar YS, (2004) Matrix metalloproteinases in renal development. Connect Tissue Res 45: 73-85.
23. Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, et al. (2008) MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev 27: 289-302.
24. Sewards TV, Sewards MA, (2003) Input and output stations of the entorhinal cortex: superficial vs. deep layers or lateral vs. medial divisions? Brain Res Brain Res Rev 42: 243-251.
25. Robertson GL, Aycinena P, Zerbe RL, (1982) Neurogenic disorders of osmoregulation. Am J Med 72: 339-353.
26. Liedtke W, Friedman JM, (2003) Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad Sci U S A 100: 13698-13703.